Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Relay Therapeutics Inc (RLAY)

NASDAQ
Currency in USD
Disclaimer
5.89
-0.06(-1.01%)
Closed
After Hours
5.82-0.07(-1.19%)

RLAY Comments

Their S-1 states they're collaborating with D. E. Shaw Research, to gain better understanding of the 3D dynamic nature of their protein targets, to find alosteric binding sites that may be more specific in action and results in fewer adverse events.This particular drug targets a well known prtein that has failed all previous attempts because of AE The success demonstrated yesterday validates this approach.The stock has 20% short interest with 10 days to cover and is almost entirely institution owned. I suspect either a large institution is being forced to sell for unrelated reasons, or a large short has realized their mistake and is manipulating the price, by triggering asell circuit breaker, in order to cover.
someone have more info for this company ?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.